Literature DB >> 9834377

Does extended pancreaticoduodenectomy increase operative morbidity and mortality vs. standard pancreaticoduodenectomy?

C Iacono1, L Bortolasi, E Facci, G Falezza, G Prati, G Mangiante, G Serio.   

Abstract

The poor prognosis of pancreatic carcinoma after resection is related to distant metastases and local recurrence that is characterized by a strong tendency to infiltrate the retroperitoneal tissue and spread along the neural plexuses and lymph nodes. Thorough clearance of these tissues around the celiac and mesenteric axes, aorta, and inferior vena cava from the diaphragm to the inferior mesenteric artery (extended pancreaticoduodenectomy may lower the rate of local recurrence, but the procedure has been criticized for its higher morbidity and mortality. Our aim was to compare extended pancreaticoduodenectomy (EPD) with standard pancreaticoduodenectomy (SPD) in terms of postoperative morbidity and mortality. Data from 47 patients who underwent either EPD (n=24) or SPD (n=23) between November 1992 and October 1995 were retrospectively analyzed. Preoperative laboratory findings, operative risk (according to the American Society of Anesthesiologists classification), type of operation (classic Whipple vs. pylorus-preserving Whipple), operative time, intraoperative blood and plasma transfusion, postoperative morbidity and mortality, and postoperative hospital stay were scrutinized. The results showed that all of the parameters considered were similar in the EPD and SPD groups (intraoperative blood transfusion 800+/-490 ml vs. 700+/-586 ml, postoperative mortality 0% vs. 4.3%, overall morbidity 45.8% vs. 47.8%, surgical morbidity 37.5% vs. 34.7%, and postoperative hospital stay 16+/-8.1 days vs. 17+/-13.1 days. These two groups differed only in the operative time, which was significantly longer for EPD than for SPD (360+/-68.9 minutes vs. 330=66.9 minutes, P=0.02). Although the operative time is increased with EPD, there does not appear to be an increase in intraoperative complications, postoperative morbidity and mortality, or postoperative hospital stay with this procedure. However, definitive confirmation of these results can only be provided by a prospective randomized study.

Entities:  

Mesh:

Year:  1997        PMID: 9834377     DOI: 10.1016/s1091-255x(97)80132-1

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  53 in total

1.  Surgical curability and prognosis for standard versus extended resection for T1 carcinoma of the pancreas.

Authors:  K Satake; H Nishiwaki; H Yokomatsu; Y Kawazoe; K Kim; A Haku; K Umeyama; I Miyazaki
Journal:  Surg Gynecol Obstet       Date:  1992-09

2.  Survival in 1001 patients with carcinoma of the pancreas.

Authors:  M M Connolly; P J Dawson; F Michelassi; A R Moossa; F Lowenstein
Journal:  Ann Surg       Date:  1987-09       Impact factor: 12.969

3.  Radical one-state pancreaticoduodenectomy.

Authors:  C G CHILD
Journal:  Surgery       Date:  1948-03       Impact factor: 3.982

4.  Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer.

Authors:  J L Cameron; D W Crist; J V Sitzmann; R H Hruban; J K Boitnott; A J Seidler; J Coleman
Journal:  Am J Surg       Date:  1991-01       Impact factor: 2.565

5.  The advantages of bypass operations over radical pancreatoduodenectomy in the treatment of pancreatic carcinoma.

Authors:  G Crile
Journal:  Surg Gynecol Obstet       Date:  1970-06

Review 6.  Arguments against radical (extended) resection for adenocarcinoma of the pancreas.

Authors:  C J Yeo; J L Cameron
Journal:  Adv Surg       Date:  1994

Review 7.  Arterial hemorrhage after pancreatoduodenectomy. The 'sentinel bleed'.

Authors:  J T Brodsky; A D Turnbull
Journal:  Arch Surg       Date:  1991-08

8.  Lymph node metastases in carcinoma of the head of the pancreas region.

Authors:  A Nakao; A Harada; T Nonami; T Kaneko; H Murakami; S Inoue; Y Takeuchi; H Takagi
Journal:  Br J Surg       Date:  1995-03       Impact factor: 6.939

9.  Optimal management of the pancreatic remnant after pancreaticoduodenectomy.

Authors:  S G Marcus; H Cohen; J H Ranson
Journal:  Ann Surg       Date:  1995-06       Impact factor: 12.969

10.  Pancreatic anastomotic leak after pancreaticoduodenectomy: incidence, significance, and management.

Authors:  J J Cullen; M G Sarr; D M Ilstrup
Journal:  Am J Surg       Date:  1994-10       Impact factor: 2.565

View more
  4 in total

1.  Results of pancreaticoduodenectomy for pancreatic cancer: extended versus standard procedure.

Authors:  Calogero Iacono; Simone Accordini; Luca Bortolasi; Enrico Facci; Giuseppe Zamboni; Ettore Montresor; Peter Domenico Marinello; Giovanni Serio
Journal:  World J Surg       Date:  2002-09-26       Impact factor: 3.352

2.  Standard vs. radical pancreaticoduodenectomy for periampullary adenocarcinoma: a prospective, randomized trial evaluating quality of life in pancreaticoduodenectomy survivors.

Authors:  Tom C Nguyen; Taylor A Sohn; John L Cameron; Keith D Lillemoe; Kurtis A Campbell; JoAnn Coleman; Patricia K Sauter; Ross A Abrams; Ralph H Hruban; Charles J Yeo
Journal:  J Gastrointest Surg       Date:  2003-01       Impact factor: 3.452

3.  Treatment of pancreatic cancer: challenge of the facts.

Authors:  Hans G Beger; Bettina Rau; Frank Gansauge; Bertram Poch; Karl-Heinz Link
Journal:  World J Surg       Date:  2003-08-21       Impact factor: 3.352

4.  Adenocarcinoma of the ampulla of Vater: T-stage, chromosome 17p allelic loss, and extended pancreaticoduodenectomy are relevant prognostic factors.

Authors:  Calogero Iacono; Giuseppe Verlato; Giuseppe Zamboni; Aldo Scarpa; Ettore Montresor; Paola Capelli; Luca Bortolasi; Giovanni Serio
Journal:  J Gastrointest Surg       Date:  2007-05       Impact factor: 3.267

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.